Inovio Pharmaceuticals
INO
INO
113 hedge funds and large institutions have $26.2M invested in Inovio Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 32 reducing their positions, and 25 closing their positions.
Holders
113
Holders Change
-11
Holders Change %
-8.87%
% of All Funds
1.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
23
Reduced
32
Closed
25
Calls
$313K
Puts
$29K
Net Calls
+$284K
Net Calls Change
+$72K
Top Buyers
| 1 |
GCP
1
GSA Capital Partners
London,
United Kingdom
|
$1.94M |
| 2 |
2
Renaissance Technologies
New York
|
$3.72M |
| 3 |
3
Morgan Stanley
New York
|
$553K |
| 4 |
4
Acadian Asset Management
Boston,
Massachusetts
|
$452K |
| 5 |
5
Amundi
Paris,
France
|
$120K |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$215K |
| 2 |
2
D.E. Shaw & Co
New York
|
$1.38M |
| 3 |
3
BlackRock
New York
|
$2.01M |
| 4 |
GC
4
GMT Capital
Atlanta,
Georgia
|
$0 |
| 5 |
5
Two Sigma Investments
New York
|
$168K |
